Account
Insider Insights
14.07.2022
HRA pharma bids to bring first OTC contraceptive p

Access to birth control is more important than ever after Roe v Wade was struck down, amid reports t...

Read more
Insider Insights
23.06.2022
NICE publish their new real world evidence framewo

NICE have been clear that this framework should not be interpreted as minimum standards for real-wor...

Read more
Insider Insights
21.06.2022
Sweden TLV considers cost containment measures

According to the TLV, “The prices of medicines that have been on the market between 5 and 15 years...

Read more
Insider Insights
09.06.2022
UK launch of innovative medicines fund

Through the new fund, £340 million is to be made available to purchase promising, potentially life-...

Read more
Insider Insights
26.05.2022
G-BA awards highest rating to Trodelvy

The drug was judged to offer an indication of major additional benefit in adult patients with advanc...

Read more
Insider Insights
04.05.2022
The European Health Data Space launch

The EHDS will integrate three main product markets for primary use of health data: electronic health...

Read more
Insider Insights
04.05.2022
UK second lowest across major health outcomes

The data is derived from the Organisation for Economic Co-operation and Development (OECD) Health St...

Read more
Insider Insights
05.04.2022
IPCEI to promote development of gene and cell ther

The IPCEI was signed to address the need to equip Europe with a strong, innovative and export-friend...

Read more
Insider Insights
24.03.2022
“First of its kind” MAA leads to NICE approval

The draft final guidance reverses previous guidance issued in November 2021 rejecting the drug for r...

Read more
Insider Insights
09.03.2022
Requirement lifted for a number of products

Paracetamol and ibuprofen combinations are set to become available in pharmacies without a prescript...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.